Teva's anastrozole label supplement approved; Sanofi duvakitug HS trial still recruitingNov 9Weekly roundup, 2 itemsanastrozoleduvakitug
Teva completes Phase 3 asthma inhaler trial; registers vitiligo program and five ANDA actionsNov 6Weekly roundup, 8 itemsalbuterolduvakitug
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Teva Pharmaceutical adds David Brailer to board of directorsOct 29PeopleTeva Pharmaceutical Industries Ltd
Genentech's mycophenolate pregnancy registry listed as completed, last updated October 2026Oct 16Weekly roundup, 4 itemsAmneal Pharmaceuticals, LLCastegolimabUpdated
FDA approves Teva's Degevma, a denosumab biosimilar-type productSep 25Regulatory decisiondenosumabdenosumab-adet
FDA clears three labeling supplements for palonosetron, letrozole, carbamazepineSep 17Weekly roundup, 3 itemscarbamazepineletrozole
Teva subsidiaries price $3.2 billion and €1.5 billion in new senior notesSep 16FinancingTeva Pharmaceutical Industries Ltd
Teva gets labeling supplement approved for injectable PaclitaxelSep 11Regulatory decisionpaclitaxelTeva Pharmaceutical Industries Ltd
Teva prices multi-tranche notes offering to fund redemption of five outstanding bond seriesSep 8FinancingTeva Pharmaceutical Industries Ltd
Actavis Labs FL secures four labeling supplement approvals for bupropion HCl SRSep 2Regulatory decisionbupropionTeva Pharmaceutical Industries Ltd
Teva gets FDA approval for generic tofacitinib citrate ER; two Claravis labeling supplements clearedAug 21Weekly roundup, 3 itemsTeva Pharmaceutical Industries Ltdtofacitinib
FDA clears five ANDA supplements for Teva and Actavis Labs generics, mostly labeling updatesAug 14Weekly roundup, 5 itemsTeva Pharmaceutical Industries Ltd
Actavis Labs UT's clindamycin/benzoyl peroxide gel ANDA shows FDA approval letter dated August 20, 2Aug 7Regulatory decisionbenzoyl peroxideclindamycin
Teva posts Q2 2026 GAAP loss on Emalex charge, raises innovative brand outlookJul 29Quarterly updatedeutetrabenazinefremanezumab-vfrm
Teva gets ANDA approval for sugammadex sodium injection; four mycophenolate REMS updates clearedJul 29Weekly roundup, 5 itemsmycophenolatesugammadex
Teva gets ANDA approval for tolvaptan generic; Ziac label updatedJul 24Weekly roundup, 2 itemsbisoprolol fumarate and hydrochlorothiazideTeva Pharmaceutical Industries Ltd
FDA approves Teva's generic eltrombopag olamine tablets in three strengthsJul 13Regulatory decisioneltrombopagTeva Pharmaceutical Industries Ltd
FDA approves labeling supplement for Actavis's orally disintegrating risperidone tabletsJul 1Regulatory decisionrisperidoneTeva Pharmaceutical Industries Ltd